Annual Meeting สาธารณะ
[search 0]
เพิ่มเติม

ดาวน์โหลดแอปเลย!

show episodes
 
The audio feed of American Academy of Religion (AAR), the world's largest scholarly and professional association of academics, teachers, and research scholars dedicated to furthering knowledge of religions and religious institutions in all their forms and manifestations. Featuring interviews with award-winning scholars and sessions recorded during the Annual Meeting of the American Academy of Religion.
 
This podcast is sponsored by Enceladus Capital, an investment management firm whose investment philosophy is inspired by the original 1950’s Buffett partnerships (Fair fee structure with 0% mgmt fee; 25% performance allocation over a 6% pa compounding hurdle). Please visit https://enceladuscapital.com/ for more details.
 
Yahoo Finance is thrilled to be the exclusive online host of the 2020 Berkshire Hathaway Annual Shareholders Meeting on May 2nd. This year, we are bringing it to you again in podcast form. Come listen to Chairman and CEO Warren Buffett and his right-hand man Charlie Munger as they share their unscripted views on the company, the markets, the economy, and a whole lot more.
 
N
Nature Video

1
Nature Video

Unsubscribe
Unsubscribe
รายเดือน
 
Nature Video presents short films from the annual Meeting of Nobel laureates in Lindau, Germany. The films capture the views of young scientists and Nobel Laureates as they discuss the future of their subjects and the nature of scientific discovery. In 2014 the meeting was all about Physiology and Medicine, a topic last covered at the meeting of 2010. In 2013 & 2009 the meetings were dedicated to Chemistry, and in 2012 and 2008 they were dedicated to physics. In 2010, Lindau hosted a special ...
 
Loading …
show series
 
Proceedings from part 1 of a 4-part webinar series. Featuring perspectives from Drs Daniel A Pollyea, Eytan M Stein and Andrew H Wei on the following topics: Introduction (0:00) Venetoclax combinations (16:54) FLT3 inhibitors (34:31) IDH inhibitors (43:42) Oral azacitidine (CC-486) (50:45) Secondary AML (57:49) Novel agents and strategies (1:01:05)…
 
Featuring slide presentations and related discussion from Drs Joel W Neal and Paul K Paik, including the following topics: Early Stage and Targeted Therapy in NSCLC — Joel W Neal, MD, PhD (0:00) Management of NSCLC with ALK or ROS1 Rearrangements or Alterations in HER2, NTRK or KRASG12C — Paul K Paik, MD (34:02) CME information and select publicati…
 
Featuring perspectives from Drs Joel W Neal and Paul K Paik on the following topics: Introduction (0:00) Case: A 67-year-old man, never smoker with symptomatic metastatic adenosquamous carcinoma of the lung (1:33) Targeting ROS1 rearrangements in non-small cell lung cancer (NSCLC) (9:07) EGFR exon 19 deletion and exon 21 (L858R) point mutation in N…
 
Featuring a roundtable discussion Drs Sergio A Giralt, Jonathan L Kaufman and Peter Voorhees, including the following topics: Case: A woman in her mid-70s with newly diagnosed multiple myeloma (MM) and trisomy in chromosomes 3, 9 and 11 — Neil Morganstein, MD (0:00) Role of autologous stem cell transplant (ASCT) in the management of MM; minimal res…
 
Featuring slide presentations and related discussion from Drs Harold J Burstein and Lisa Carey, including the following topics: ER-Positive Breast Cancer, PARP Inhibitors and Sacituzumab Govitecan — Harold J Burstein, MD, PhD (0:00) HER2-Positive and Triple-Negative Breast Cancer — Lisa A Carey, MD (43:52) CME information and select publications…
 
Featuring perspectives from Drs Harold J Burstein and Lisa Carey on the following topics: ER-Positive, HER2-Negative Breast Cancer Introduction (0:00) CDK4/6 inhibitors for ER-positive breast cancer (3:53) Role of PI3K inhibitors for ER-positive metastatic breast cancer (mBC) (13:31) Use of genomic assays for patients with ER-positive breast cancer…
 
Featuring an interview with Dr Roy S Herbst, including the following topics: Localized Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:00) Phase III ADAURA Trial — Study Design and Characteristics of Enrolled Patients (3:32) Efficacy Data from the Phase III ADAURA Study Evaluating Adjuvant Osimertinib in Resected NSCLC with an EGFR Muta…
 
Featuring perspectives from Drs Michael J Birrer, Kathleen Moore and David M O'Malley on the following topics: Introduction 0:00) Symptoms of ovarian cancer — Courtney Arn, CNP (7:38) Implications of genetic testing — Jaclyn Shaver, MS, APRN, CNP, WHNP (15:51) Evaluation of an ovarian mass — Paula J Anastasia, MN, RN, AOCN) (27:58) Case: A woman in…
 
Featuring slide presentations and related discussion from Dr Kristen K Ciombor and Prof Eric Van Cutsem, including the following topics: New Developments in the Use of Biomarker-Based Treatment for Metastatic Colorectal Cancer (mCRC) — Kristen K Ciombor, MD, MSCI (0:00) Key Considerations in the Selection and Sequencing of Therapies for Patients wi…
 
Featuring perspectives from Dr Kristen K Ciombor and Prof Eric Van Cutsem, including the following topics: Introduction (0:00) Case: A woman in her mid-60s with microsatellite stable (MSS) right-sided metastatic colorectal cancer (mCRC) with a KRAS G13B mutation and a tumor mutation burden (TMB) of 11 mut/Mb — Warren S Brenner, MD (3:00) Case: A wo…
 
Featuring an interview with Dr Laurie H Sehn on the following topics: Updates in diffuse large B-cell lymphoma (0:00) New data with mantle cell lymphoma (14:27) Latest clinical findings in Hodkin lymphoma and peripheral T-cell lymphoma (22:43) CME information and select publicationsโดย Dr. Neil Love
 
Featuring a roundtable discussion with Drs Virginia F Borges, Sara Hurvitz and Ian E Krop, including the following topics: Introduction Impact of COVID-19 vaccinations on screening for breast cancer (0:00) Management of HER2-positive early breast cancer Case: A woman in her early 40s with ER/PR-positive, HER2-positive breast cancer achieves a patho…
 
Featuring an interview with Dr Natalie S Callander, including the following topics: Treatment of high-risk smoldering multiple myeloma (MM) with carfilzomib, lenalidomide and dexamethasone followed by maintenance lenalidomide: A Phase II clinical and correlative study (0:00) Early versus late autologous stem cell transplant for newly diagnosed MM: …
 
Proceedings from the first of 2 sessions on HER2-positive breast cancer. Featuring perspectives from Dr Erika Hamilton, including the following topics: Introduction and review of SABCS 2020 Educational Session on HER2-targeted therapy (0:00) Case: A 42-year-old premenopausal woman with ER-positive, HER2-positive, node-negative breast cancer — Lauri…
 
Proceedings from the first of 2 sessions on triple-negative breast cancer. Featuring perspectives from Dr P Kelly Marcom, including the following topics: Introduction and Review of San Antonio Breast Cancer Symposium 2020 Educational Session on Triple-Negative Breast Cancer (TNBC) (0:00) Optimal Integration of Immune Checkpoint Inhibitors into the …
 
Through a case study of Zava Damdin, a monk living on the frontier of the Mongolia at the end of the Qing empire (early 20th c), Matthew King invites scholars to consider non-Eurocentric ways of studying religion in modern history.King is assistant professor in transnational Buddhism in the Department of Religious Studies at the University of Calif…
 
Featuring slide presentations and related discussion from Drs Sumanta K Pal and David I Quinn, including the following topics: Renal Cell Cancer — David I Quinn, MBBS, PhD (0:00) Urothelial Bladder Cancer — Sumanta K Pal, MD (41:35) CME information and select publicationsโดย Dr. Neil Love
 
Featuring perspectives from Drs Sumanta K Pal and David I Quinn on the following topics: Renal Cell Carcinoma Introduction (0:00) First-line treatment of metastatic RCC (4:49) Relapsed disease (21:26) Urothelial Bladder Cancer (UBC) Immune checkpoint inhibitors (ICIs) for non-muscle-invasive UBC (24:59) (Neo)adjuvant ICIs (28:26) ICIs with or witho…
 
Featuring slide presentations and related discussion from Drs Rafael Fonseca and Jonathan L Kaufman, including the following topics: Customized induction and maintenance approaches for newly diagnosed MM; select new developments in relapsed/refractory disease — Rafael Fonseca, MD (0:00) Newly approved and promising investigational agents for patien…
 
Featuring perspectives from Drs Rafael Fonseca and Jonathan L Kaufman on the following topics: Customized induction and maintenance approaches for newly diagnosed MM (0:00) Newly approved and promising investigational agents for MM (28:53) CME information and select publicationsโดย Dr. Neil Love
 
Featuring an interview with Dr Roberto Iacovelli on the following topics: New hormonal therapies for prostate cancer (0:00) Risk of cardiovascular adverse events with new hormonal therapies for prostate cancer (2:45) Metabolic syndrome related to new hormonal therapies for prostate cancer (9:50) Bone fractures with androgen deprivation therapy (ADT…
 
Featuring an interview with Dr Harry Paul Erba, including the following topics: Improvement in overall survival in the VIALE-A trial with azacitidine/venetoclax compared to azacitidine alone for patients with previously untreated acute myeloid leukemia (AML) ineligible for intensive chemotherapy (0:00) Delay in time to deterioration of health-relat…
 
Featuring perspectives from Dr Michael J Birrer on the following topics: Anti-PD-1/PD-L1 Checkpoint Inhibitors for Gynecologic Cancers (0:00) HER2-Positive Endometrial Cancer (43:24) Tisotumab Vedotin and Other Novel Agents in Gynecologic Cancers (47:57) CME information and select publicationsโดย Dr. Neil Love
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Gastroesophageal Cancers — Faculty Presentation 1: Evolving Front-Line Management of Advanced Gastric/Gastroesophageal Junction (GEJ) Cancer — Dr Janjigian. CME information and select publicationsโดย Dr. Neil Love
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Gastroesophageal Cancers — Faculty Presentation 2: Optimal Management of HER2-Positive and FGFR2-Positive Gastroesophageal Cancers — Dr Catenacci. CME information and select publicationsโดย Dr. Neil Love
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Gastroesophageal Cancers — Faculty Presentation 3: Selection and Sequencing of Therapies for Relapsed Gastric/GEJ Cancer; Novel Investigational Approaches — Dr Mehta. CME information and select publicationsโดย Dr. Neil Love
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Gastroesophageal Cancers — Faculty Presentation 4: Key Findings Informing the Treatment of Localized and Advanced Esophageal Cancer — Dr Wainberg. CME information and select publicationsโดย Dr. Neil Love
 
Featuring perspectives from Drs Daniel Catenacci, Yelena Y Janjigian, Rutika Mehta and Zev Wainberg on the following topics: Introduction (0:00) Evolving Front-Line Management of Advanced Gastric/Gastroesophageal Junction (GEJ) Cancer (2:39) Localized and Advanced Esophageal Cancer; Novel Strategies with Immunotherapy in GEJ Cancer (20:27) Selectio…
 
Featuring an interview with Dr Manmeet Ahluwalia on the following topics: Management of CNS metastases in patients with non-small cell lung cancer (NSCLC) (0:00) Case: A woman in her mid-40s with NSCLC and an EGFR mutation who presented with multiple brain metastases receives stereotactic radiosurgery (SRS) and osimertinib on a clinical trial (29:0…
 
Prostate Cancer Update, Issue 2, 2021 — Part 1: Our interview with Dr Ryan highlights the following topics as well as cases from his practice: Practical factors influencing the selection of therapy for patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC) (0:00) Case: A ma…
 
Prostate Cancer Update, Issue 2, 2021 — Part 2: Our most recent one-on-one interview with Professor de Bono featuring emerging research and cases from his practice: Current and future management of metastatic castration-resistant prostate cancer (mCRPC); role of PARP inhibition as a therapeutic strategy (0:00) Choice of therapy for patients with mC…
 
Featuring an interview with Dr Gilles Salles on the following topics: Novel and emerging strategies for diffuse large B-cell lymphoma (DLBCL) (0:00) Available efficacy and safety data with the antibody-drug conjugate polatuzumab vedotin for DLBCL (1:01) Mechanism of action of selinexor, the novel selective inhibitor of nuclear export; key efficacy …
 
Featuring slide presentations and related discussion from Drs Matthew Gubens and Suresh S Ramalingam, including the following topics: Nontargeted Therapies for Metastatic Non-Small Cell Lung Cancer — Matthew Gubens, MD, MS (0:00) Small Cell Lung Cancer and Mesothelioma — Suresh S Ramalingam, MD (35:33) CME information and select publications…
 
Featuring perspectives from Drs Matthew Gubens and Suresh S Ramalingam, including the following topics: Introduction (0:00) Non-Small Cell Lung Cancer (7:55) Malignant Pleural Mesothelioma (34:03) Small Cell Lung Cancer (43:30) CME information and select publicationsโดย Dr. Neil Love
 
Featuring an interview with Dr Andrew H Wei on the following topics: Treatment of acute myeloid leukemia (AML) in patients not eligible for intensive induction therapy (0:00) Case: A man in his late 70s with AML receives re-treatment with venetoclax and azacitidine after attaining a durable remission of 2.5 years with that regimen (21:23) Case: A w…
 
Featuring slide presentations and related discussion from Drs Christopher R Flowers and Sonali M Smith on the following topics: Follicular Lymphoma (FL) and Mantle-Cell Lymphoma (MCL) — Christopher R Flowers, MD, MS (0:00) Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma — Sonali M Smith, MD (40:22) CME information and select publications…
 
Proceedings from a webinar featuring key clinical presentations and papers in lymphomas. Featuring perspectives from Drs Christopher R Flowers and Sonali M Smith on the following topics: Introduction (0:00) Follicular lymphoma (2:24) Mantle cell lymphoma (15:01) Diffuse large B-cell lymphoma (23:48) Hodgkin lymphoma (39:37) CAR T-cell therapy (50:1…
 
Featuring an interview with Prof Solange Peters on the following topics: Emerging biomarkers for predicting response to cancer immunotherapy (0:00) Case: A man in his late 50s with metastatic pleomorphic carcinoma of the lung and a high tumor mutational burden (TMB) attains a complete response to pembrolizumab (25:43) Role of TMB in determining res…
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Hepatocellular Carcinoma — Faculty Presentation 1: Front-Line Management for Advanced Hepatocellular Carcinoma (HCC) — Dr Kaseb. CME information and select publicationsโดย Dr. Neil Love
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Hepatocellular Carcinoma — Faculty Presentation 2: Selection and Sequencing of Treatment for Patients with Relapsed HCC — Dr Greten. CME information and select publicationsโดย Dr. Neil Love
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Hepatocellular Carcinoma — Faculty Presentation 3: Considerations for the Treatment of HCC in Special Patient Populations — Dr Harding. CME information and select publicationsโดย Dr. Neil Love
 
Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Hepatocellular Carcinoma — Faculty Presentation 4: New Directions in the Management of HCC — Dr Finn. CME information and select publicationsโดย Dr. Neil Love
 
Featuring perspectives from Drs Richard S Finn, Tim Greten, James J Harding and Ahmed Omar Kaseb on the following topics: Introduction (0:00) Front-Line Management for Advanced Hepatocellular Carcinoma (HCC) (1:40) Selection and Sequencing of Treatment for Patients with Relapsed HCC (33:41) Considerations for the Treatment of HCC in Special Patient…
 
Featuring an interview with Dr Joseph Mikhael on the following topics: Recently approved agents for multiple myeloma (MM) (0:00) Case: A man in his mid-70s with standard-risk MM receives isatuximab with pomalidomide and dexamethasone as second-line therapy (22:15) Case: A woman in her mid-70s with high-risk MM receives selinexor and dexamethasone a…
 
Featuring an interview with Dr Zofia Piotrowska on the following topics: Current and emerging strategies for patients with non-small cell lung cancer (NSCLC) harboring an EGFR exon 20 insertion mutation (0:00) Case: A woman in her mid-50s with metastatic NSCLC and an EGFR exon 20 insertion receives mobocertinib as second-line therapy on a clinical …
 
Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Chronic Lymphocytic Leukemia — Faculty Presentation 1: Treatment Options for Younger, Fit Patients with Chronic Lymphocytic Leukemia (CLL) — Dr Barr. CME information and select publications…
 
Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Chronic Lymphocytic Leukemia — Faculty Presentation 2: Up-Front Management of CLL in Patients Who Are Older or Have Comorbidities — Dr Stilgenbauer. CME information and select publications…
 
Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Chronic Lymphocytic Leukemia — Faculty Presentation 3: Optimal Management of Adverse Events Associated with BTK and Bcl-2 Inhibitors — Dr Davids. CME information and select publications…
 
Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Chronic Lymphocytic Leukemia — Faculty Presentation 4: Selection and Sequencing of Therapies for Relapsed/Refractory CLL — Dr Rogers. CME information and select publications…
 
Loading …

คู่มืออ้างอิงด่วน

Google login Twitter login Classic login